Back
Perspective Therapeutics Vs. BioNTech SE Industry Stock Comparison
Sell
31
CATX
Perspective Therapeutics
Last Price:
13.55
Seasonality Move:
-10.19%
Sell
49
BNTX
BioNTech SE
Last Price:
112.39
Seasonality Move:
12.7%
Sell
31
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $13.47. The Score for CATX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
BioNTech SE (BNTX)
is a Sell
Is BioNTech SE a Buy, Sell or Hold?
- The current BioNTech SE [BNTX] share price is $112.51. The Score for BNTX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- BNTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $13.47
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
BNTX Stock Price Chart
What is BioNTech SE's stock price today?
-
The BioNTech SE share price today is $112.51
The current trend is moderately bullish and BNTX is experiencing slight selling pressure.
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 42.96 | Sell |
Chaikin Money Flow: | -538312 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.95 - 15.75) | Sell |
Bollinger Bands (100): | (11.53 - 15.95) | Sell |
BNTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.5 | Buy |
Relative Strength Index (14 RSI): | 65.41 | Buy |
Chaikin Money Flow: | -684853 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (83.83 - 109.47) | Buy |
Bollinger Bands (100): | (81.16 - 100) | Buy |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.46 | Sell |
20-day SMA: | 14.98 | Sell |
50-day SMA: | 13.73 | Sell |
200-day SMA: | 11.27 | Buy |
8-day EMA: | 14.11 | Sell |
20-day EMA: | 14.44 | Sell |
50-day EMA: | 13.95 | Sell |
200-day EMA: | 11.5 | Buy |
BNTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 113.1 | Sell |
20-day SMA: | 98.82 | Buy |
50-day SMA: | 90.18 | Buy |
200-day SMA: | 93.15 | Buy |
8-day EMA: | 112.32 | Buy |
20-day EMA: | 102.78 | Buy |
50-day EMA: | 94.47 | Buy |
200-day EMA: | 94.88 | Buy |
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.
BioNTech SE Earnings Growth & BNTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.72 per share, an increase next quarter of $0.10 per share, a decrease this year of $7.38 per share, and a decrease next year of $0.37 per share.
Perspective Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
BioNTech SE Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |